Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Osteoarthritis Drugs Market

Osteoarthritis Drugs Market Analysis

  • Report ID: GMI8580
  • Published Date: Mar 2024
  • Report Format: PDF

Osteoarthritis Drugs Market Analysis

Based on the drug type, the global market is classified into viscosupplementation agents, nonsteroidal anti-inflammatory drugs, analgesics, corticosteroids, and other drug types. The viscosupplementation agents drug type segment dominated the market with revenue of USD 3 billion in 2023.

  • These agents are made of hyaluronic acid and provide lubrication and cushioning to the affected joints, lowering pain and increasing mobility. Also, they offer a minimally invasive therapeutic alternative to individuals with mild to moderate osteoarthritis who have not responded well to conventional treatments. According to the article published by NCBI in July 2021, viscosupplementation with hyaluronic acid injections effectively decreases pain and improves functionality, hence delaying surgery. Thus, availability of such varying evidence, viscosupplementation alternatives have a safe profile and demonstrated efficacy, contributing significantly to OA symptom management, thereby augmenting the market growth.

Osteoarthritis Drugs Market, By Route of Administration (2023)

Based on route of administration, the osteoarthritis drugs market is classified into oral, parenteral, topical. The parenteral segment held highest market share of 41.5% in 2023.

  • The segmental growth is attributable to the factors such as better pharmacokinetics and pharmacodynamics, efficacy for certain therapies, and ease of administration.
  • Also, parenteral administration routes offer a viable solution for delivering osteoarthritis drugs to elderly patients who may have difficulty swallowing pills or have gastrointestinal issues. Thus, the growing aging population presents a significant demographic driver for the demand for parenteral administration routes in osteoarthritis treatment.

Based on anatomy, the osteoarthritis drugs industry is classified into ankle osteoarthritis, hip osteoarthritis, knee osteoarthritis, shoulder osteoarthritis, and other anatomies. The knee osteoarthritis segment is expected to hold the highest revenue throughout the forecast period.

  • The increased awareness of knee osteoarthritis, rising prevalence of knee osteoarthritis, and the growing elderly population are all key factors driving the segmental growth.
  • According to a PubMed Central article published in June 2022, knee osteoarthritis (OA) is a degenerative joint condition and one of the leading causes of knee joint replacements in the U.S. Thus, it enhances the demand for therapeutic drugs for treatment, thereby propelling the market growth forward.

Based on medication, the osteoarthritis drugs market is classified into prescription and over-the-counter (OTC) drugs. The over-the-counter segment held highest share of 56.7% in 2023.

  • The growth of the over-the-counter (OTC) segment in the market is driven by several factors including the broad availability of OTC medications without the need for prescriptions, rising patients' inclination towards convenient self-care alternatives.
  • Also, cost-effectiveness in comparison to prescription drugs, increased awareness and education regarding osteoarthritis treatments, escalating healthcare expenditures, and a shift towards patient empowerment and self-management of health conditions are few of the other factors that contribute to the substantial expansion of the OTC segment in the market.

Based on distribution channel, the market is classified into hospital pharmacies, retail pharmacies, and online pharmacy. The hospital pharmacies segment held the highest CAGR of 7.2% over forecast period.

  • Hospital pharmacists along with orthopedissc professionals are taking on expanded roles in providing medication therapy management services to osteoarthritis patients. This may include medication counseling, adherence monitoring, dosage adjustments, and therapeutic interventions to optimize treatment outcomes and minimize adverse effects, thereby enhancing patient care and satisfaction.

North America Osteoarthritis Drugs Market, 2020 – 2032 (USD Billion)

In 2023, North America secured a substantial market share of 41.1% in 2023 and is expected to dominate throughout the forecast period.

  • The factors such as the increasing prevalence of osteoarthritis, supportive government policies, and product launches in the region is expected to contribute significantly to the market's growth over the projection period.
  • Moreover, the aging population in North America is growing, leading to a higher prevalence of osteoarthritis diseases. This demographic trend along with presence of key players in the market is driving the product demand, thereby supplementing the regional market growth.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The gas analyzer systems market in North America was reached USD 976.2 million in 2023 and is projected to record a CAGR of 5.3% through 2032, driven by the increasing adoption of online continuous monitoring systems and stringent environmental regulations aimed at reducing air pollution and emissions.

Electrochemical gas analyzer systems segment held a dominant market share in 2023 in North America and is poised to cross USD 460 million by 2032, driven by escalating emission levels across diverse end-use sectors.

U.S. gas analyzer systems industry surpass USD 1.10 billion by 2032, driven by the growing emphasis on improving industrial processes' efficiency and safety, along with technological advancements, particularly in sensor technology and data analytics.

ABB, Acoem., AMETEK. Inc., AVL, Dragerwerk AG & Co.KGaA, DURAG GROUP, Emerson ElectricCo.,ENVEA, Figaro Engineering Inc., General Electric, Honeywell International Inc are some of the major industry contenders.

Osteoarthritis Drugs Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 326
  • Countries covered: 19
  • Pages: 260
 Download Free Sample